slides · global inventory
Frame Problem
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 5,849
Current window 4,591-4,620
Pages 195
Rows per page 30
Slide function
4,591-4,620 of 5,849
23
Includes survival curves, immunohistochemistry images, genetic association data, and clinical trial data for atopic dermatitis.23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
04
Uses a process diagram to show the 'loop' of optimization (affinity, developability, toxicity) leading to suboptimal outcomes.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
05
Uses a visual comparison between small molecule data availability and biologic data scarcity.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Why nowLoop · Cost Of Inaction1 hit
07
The slide uses a map to show regional prevalence and a nested circle diagram to show the funnel from total infected to treated patients.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
30
The slide presents clinical evidence linking AXL expression to poor patient outcomes in two different cohorts.BioAtla | Investor Presentation Deck | 55 slides · BioAtla
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
04
Uses a two-column comparison for Sepsis vs Septic Shock, followed by two rows of key metrics.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
05
The slide uses a process flow diagram to contrast time-to-diagnosis and a bar chart to illustrate the exponential mortality risk of delayed treatment.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
08
The slide uses a problem-solution framing, identifying the biomarker's potential and the specific pain point (time-sensitivity) that the Symphony IL-6 assay solves.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
04
Uses a visual metaphor of fluid dynamics (beakers and spheres) to explain viscosity reduction.Comera | Investor Presentation Deck | 16 slides · Comera
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
26
Illustrates the inefficiency of manual scheduling processes.D-Wave | Investor Day Presentation Deck | 133 slides · D-Wave
Conference presentation Investor relations 1 hit
28
The slide uses a specific customer case study (Pattison Food Group) to frame a problem solvable by D-Wave's quantum optimization.D-Wave | Investor Day Presentation Deck | 133 slides · D-Wave
Conference presentation Investor relations 1 hit
30
The slide maps business rules for workforce management to mathematical optimization equations.D-Wave | Investor Day Presentation Deck | 133 slides · D-Wave
Conference presentation Investor relations 1 hit
38
The slide illustrates a manual, labor-intensive scheduling workflow involving multiple constraints and ongoing maintenance.D-Wave | Investor Day Presentation Deck | 133 slides · D-Wave
Conference presentation Investor relations 1 hit
50
The diagram shows a temporal progression (t0 to tn) of satellite tracking tasks being coordinated across multiple radar stations.D-Wave | Investor Day Presentation Deck | 133 slides · D-Wave
Conference presentation Investor relations 1 hit
51
The slide uses a contrast between a simple 1D scheduling chart and a complex 3D global visualization to frame the problem of combinatorial optimization.D-Wave | Investor Day Presentation Deck | 133 slides · D-Wave
Conference presentation Investor relations 1 hit
61
D-Wave | Investor Day Presentation Deck | 133 slidesD-Wave | Investor Day Presentation Deck | 133 slides · D-Wave
Conference presentation Investor relations 1 hit
62
Includes a definition of NP complexity and practical applications of TSP.D-Wave | Investor Day Presentation Deck | 133 slides · D-Wave
Conference presentation Investor relations 1 hit
63
The slide uses a structured list format to define geographic, store-specific, and logistical constraints for a routing or optimization problem.D-Wave | Investor Day Presentation Deck | 133 slides · D-Wave
Conference presentation Investor relations 1 hit
88
The slide uses a network optimization problem as a use case for D-Wave's quantum computing capabilities.D-Wave | Investor Day Presentation Deck | 133 slides · D-Wave
Conference presentation Investor relations 1 hit
10
The slide uses a biological diagram to explain the 'problem' of immune evasion in cancer therapy.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
10
The slide uses a visual comparison to frame the problem of current therapeutic limitations.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations Beat · Problem (Identify pain)1 hit
25
Includes a blackbox warning text block as a competitive/safety barrier context.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
16
Includes a Kaplan-Meier survival curve comparing existing standard-of-care options.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · EvidenceLoop · Quick Win Big Bet1 hit
24
The chart is a Kaplan-Meier survival curve comparing a control arm to an experimental arm (EC).Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Solution1 hit
29
The slide uses a stacked bar chart to show mutation incidence and a comparison table to highlight clinical trial failures in GBM compared to other indications.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Solution1 hit
07
The slide uses a hub-and-spoke diagram to connect a central problem (CAR-T Neurotoxicity) to four specific negative outcomes.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Problem & Complication1 hit
20
The slide uses a causal chain to link cellular pathology to systemic organ damage.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
51
The slide uses a bubble chart to map clinical trial outcomes and a table to detail specific drug performance metrics across treatment lines.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
10
The slide uses a visual timeline/process flow to explain the biological progression of the disease.Mainz Biomed NV | Investor Presentation Deck | 24 slides · Mainz Biomed
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
05
Uses a personal narrative (Shay) to humanize the disease progression alongside clinical data.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Problem1 hit